(2015). Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ann Surg Oncol.
استشهاد بنمط شيكاغو"Erratum To: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology." Ann Surg Oncol 2015.
MLA استشهاد"Erratum To: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology." Ann Surg Oncol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.